Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127171651 | 12717165 | 1 | I | 20160826 | 20160906 | 20160906 | EXP | GB-JNJFOC-20160903557 | JANSSEN | 43.00 | YR | A | M | Y | 0.00000 | 20160906 | PH | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127171651 | 12717165 | 1 | PS | TRAMADOL HYDROCHLORIDE. | TRAMADOL HYDROCHLORIDE | 1 | Oral | Y | U | 20281 | TABLETS | ||||||||
| 127171651 | 12717165 | 2 | I | WARFARIN | WARFARIN | 1 | Oral | Y | 0 | UNSPECIFIED | |||||||||
| 127171651 | 12717165 | 3 | C | BACLOFEN. | BACLOFEN | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 127171651 | 12717165 | 4 | C | RAMIPRIL. | RAMIPRIL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 127171651 | 12717165 | 5 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 127171651 | 12717165 | 6 | C | NIZATIDINE. | NIZATIDINE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 127171651 | 12717165 | 7 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 127171651 | 12717165 | 8 | C | BISOPROLOL | BISOPROLOL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 127171651 | 12717165 | 9 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127171651 | 12717165 | 1 | Product used for unknown indication |
| 127171651 | 12717165 | 2 | Product used for unknown indication |
| 127171651 | 12717165 | 3 | Product used for unknown indication |
| 127171651 | 12717165 | 4 | Product used for unknown indication |
| 127171651 | 12717165 | 5 | Product used for unknown indication |
| 127171651 | 12717165 | 6 | Product used for unknown indication |
| 127171651 | 12717165 | 7 | Product used for unknown indication |
| 127171651 | 12717165 | 8 | Product used for unknown indication |
| 127171651 | 12717165 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127171651 | 12717165 | HO |
| 127171651 | 12717165 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127171651 | 12717165 | Drug interaction | |
| 127171651 | 12717165 | Haemarthrosis | |
| 127171651 | 12717165 | Infected skin ulcer | |
| 127171651 | 12717165 | International normalised ratio increased | |
| 127171651 | 12717165 | Labelled drug-drug interaction medication error | |
| 127171651 | 12717165 | Upper gastrointestinal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |